Hypertriglyceridemic waist: A useful screening phenotype in preventive cardiology?Le tour de taille hypertriglycéridémique : Un phénotype de dépistage utile en cardiologie préventive?
References (63)
- et al.
The hypertriglyceridemic waist phenotype among women
Atherosclerosis
(2003) - et al.
Features of the metabolic syndrome of “hypertriglyceridemic waist” and transplant coronary artery disease
J Heart Lung Transplant
(2005) - et al.
Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease
Am J Cardiol
(2002) - et al.
Postprandial hyperlipidemia: Another correlate of the “hypertriglyceridemic waist” phenotype in men
Atherosclerosis
(2003) - et al.
Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration
Am J Clin Nutr
(2003) - et al.
Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype
Am J Clin Nutr
(2006) - et al.
Prevalence of the hypertriglyceridemic waist phenotype in Iranian adolescents
Am J Prev Med
(2006) - et al.
Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults
Am J Clin Nutr
(2005) - et al.
The metabolic syndrome
Lancet
(2005) Does a diagnosis of metabolic syndrome have value in clinical practice?
Am J Clin Nutr
(2006)
Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
Am J Cardiol
(1994)
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study
Lancet
(2005)
The metabolic syndrome – a new worldwide definition
Lancet
(2005)
A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
Am J Clin Nutr
(1996)
Dysglycaemia and risk of cardiovascular disease
Lancet
(1996)
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: Analysis of the Treating to New Targets study
Lancet
(2006)
Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease
JAMA
(1998)
Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men?
Circulation
(2000)
Prevalence of “hypertriglyceridemic waist” in men who participated in the Quebec Health Survey: Association with atherogenic and diabetogenic metabolic risk factors
Can J Cardiol
(2002)
Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose Study)
Int J Obes Relat Metab Disord
(2004)
Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men
Int J Obes (Lond)
(2006)
Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women
Circulation
(2005)
The hypertriglyceridaemic waist in New Zealand Maori
Asia Pac J Clin Nutr
(2004)
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol
Lipids
(2006)
Hypertriglyceridemic waist as a screening tool for CVD risk in indigenous Australian women
Ethn Dis
(2003)
Is visceral obesity the cause of the metabolic syndrome?
Ann Med
(2006)
Treatment of obesity: Need to focus on high risk abdominally obese patients
BMJ
(2001)
The metabolic syndrome: Should current criteria influence clinical practice?
Curr Opin Lipidol
(2006)
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
JAMA
(2003)
The Canadian obesity epidemic, 1985–1998
CMAJ
(2002)
Environmental contributions to the obesity epidemic
Science
(1998)
Cited by (172)
The triglyceride-waist circumference index is a valid biomarker of metabolic syndrome in African Americans
2023, American Journal of the Medical SciencesUncovering the effect and mechanism of Panax notoginseng saponins on metabolic syndrome by network pharmacology strategy
2023, Journal of EthnopharmacologyCitation Excerpt :However, the effects and mechanism of PNS on anti-MetS have not been revealed yet. Obesity leads to the development of MetS, which gains the prominence as the leading cause (Carr et al., 2004; Lemieux et al., 2007). Prevention and treatment of obesity is critical for ameliorating the symptom and progression of MetS.
The association between the hypertriglyceridaemia waist phenotype, cardiovascular risk factors and the metabolic syndrome in South African Asian-Indians
2022, Diabetes and Metabolic Syndrome: Clinical Research and ReviewsOverall, abdominal, and visceral obesity in men and women: an introduction
2022, Visceral and Ectopic Fat: Risk Factors for Type 2 Diabetes, Atherosclerosis, and Cardiovascular Disease
Copyright © 2007 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.